Celestial Biolabs (Delisted) share news and announcements

BSE: 532871Pharmaceuticals & Biotechnology

Formerly Celestial Labs

Last traded ₹1.75 on 11 Mar 2020

Delisted on 16 Oct 2024.

Celestial Biolabs share news and announcements

634 announcements, routine notices left out, newest first. Page 6 of 13.

May 2018
- 25 May · Board Meeting To Be Held On 30.05.2018
  This is to intimate you that a meeting of the Board of Directors and Audit Committee .... (opens in a new tab)
- 19 May · Results
  Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 19 May · Meeting
  Voting results of items transacted at the Extra Ordinary General Meeting of the Company held on Saturday, the 19th May, 2018 in compliance of Regulation 44 of the Securities and Exchange .... (opens in a new tab)
- 19 May · Meeting
  Proceedings of Extra Ordinary General Meeting as required under Regulation 30, Part-A of Schedule -III of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) .... (opens in a new tab)
- 19 May · Meeting
  Voting results of Extraordinary General Meeting held on May 19, 2018 (opens in a new tab)
- 19 May · Meeting
  Proceedings of Extraordinary General Meeting held on May 19, 2018 (opens in a new tab)
- 9 May · Meeting
  Notice of Extraordinary General Meeting to be held on May 19, 2018 (opens in a new tab)
- 9 May · Meeting
  Extra-ordinary General Meeting (EGM) on 19.05.2018. Notice of EGM is enclosed (opens in a new tab)
Apr 2018
- 30 Apr · Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
  Pursuant to Reg 40(9) of SEBI (LODR) Regulations, 2015, we are enclosing the certificate received from the practicing company secretary for the half year ended 31.03.2018 (opens in a new tab)
- 27 Apr · Compliance Certificate Under Reg.7(3) Of SEBI (LODR) Regulations, 2015
  Compliance certificate under Reg.7(3) of SEBI (LODR) Regulations, 2015 for the period ended 31.03.2018 (opens in a new tab)
- 19 Apr · Shareholding for the Period Ended March 31, 2018
  Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
- 19 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 10 Apr · Board meeting
  Outcome of Board meeting held on 10.04.2018 in pursuant to the Securities Exchange & Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. (opens in a new tab)
- 10 Apr · Board meeting
  Board meeting held on April 10, 2018. (opens in a new tab)
- 10 Apr · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 5 Apr · Board Meeting - Board Meeting On 10Th April, 2018
  Prior Intimation of the Board Meeting to be held on 10.04.2018 pursuant to Regulation 29(1)(d) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 5 Apr · Board meeting
  To consider Fund Raising (opens in a new tab)
Feb 2018
- 14 Feb · Board meeting
  Outcome of Board Meeting held on February 14, 2018. (opens in a new tab)
- 14 Feb · Results
  Pursuant to the Securities Exchange & Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 this is to inform you that the Board of Directors in their just .... (opens in a new tab)
- 14 Feb · Results
  Financial results for the period ended 31-Dec-2017. (opens in a new tab)
- 6 Feb · Board meeting
  1) To consider and take on record the Un-audited financial results of the Company for the quarter / nine months ended December 31, 2018 and 2) To discuss on further issue of shares or warrants. (opens in a new tab)
- 6 Feb · Prior Intimation Of The Board Meeting And Audit Committee Meeting To Be Held On 14.02.2018
  This is to intimate you that a meeting of the Board of Directors and Audit Committee .... (opens in a new tab)
Jan 2018
- 19 Jan · Statement Of Investor Complaint For The Quarter Ended December, 2017
  Statement of Investor Complaint for the quarter ended December, 2017 required under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 18 Jan · Shareholding for the Period Ended December 31, 2017
  Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
- 4 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padma Singh (opens in a new tab)
Dec 2017
Nov 2017
- 3 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr A N Singh (opens in a new tab)
- 3 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr A N Singh (opens in a new tab)
Oct 2017
- 30 Oct · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. A N Singh (opens in a new tab)
- 27 Oct · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr A N Singh (opens in a new tab)
- 27 Oct · Compliance Certificate For The Period Ended September 30, 2017
  Please find enclosed the certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year .... (opens in a new tab)
- 27 Oct · CERTIFICATE UNDER REGULATION 40 (9) OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015
  We are enclosing the certificate received from the practicing company secretary .... (opens in a new tab)
- 20 Oct
  Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017 (opens in a new tab)
- 20 Oct · Shareholding for the Period Ended September 30, 2017
  Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
- 10 Oct · Results
  Revised Financial results alongwith limited review report for the quarter ended 30th June, 2017 are enclosed (opens in a new tab)
- 3 Oct · Legal
  Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Standalone limited review report not submitted. -4. Reconciliation of profit and loss not submitted. The response of the Company is enclosed. (opens in a new tab)
Sep 2017

Celestial Biolabs share news and announcements

May 2018

Apr 2018

Feb 2018

Jan 2018

Dec 2017

Nov 2017

Oct 2017

Sep 2017